In the subgroup survival study, higher P4HB expression was associated with a reduced probability of BCR in terms of N0 stage, White population, residual tumor, age < 60, and overlapping or multiple zones than lower P4HB expression (Fig. 3b–f). This evidence concerns the gene BCR and neoplasm.